Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michele Antonio Cacia"'
Autor:
Fabiola Boccuto, Nicole Carabetta, Michele Antonio Cacia, Giuseppe Panuccio, Claudia Critelli, Ciro Indolfi, Salvatore De Rosa
Publikováno v:
European Heart Journal Supplements. 24
Introduction although transcatheter aortic valve replacement (TAVR) represents a milestone in the treatment of degenerative aortic stenosis, stroke remains an important complication compared to surgical aortic valve replacement (SAVR). Multiple magne
Autor:
Michele Antonio Cacia, Ottavia Cozzi, Aisha Gohar, Antonio Mangieri, Damiano Regazzoli Lancini, Giulio Stefanini, Bernhard Reimers, Antonio Colombo
Publikováno v:
European Heart Journal Supplements. 24
While transcatheter aortic valve replacement (TAVR) gradually emerges as first line therapy for aortic disease in most surgical risk groups, structural prosthetic degeneration remains an issue that may must be considered when planning procedures in y
Autor:
Nicole Carabetta, Sabato Sorrentino, Fabiola Boccuto, Antonio Bellantoni, Salvatore Giordano, Michele Antonio Cacia, Alberto Polimeni, Isabella Leo, Ylenia Varano, Florinda Maria Augusto, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims Post-procedural bleedings have a significant impact on mortality in patients undergoing transcatheter aortic valve replacement (TAVR). Unfortunately, the source of these bleedings is often undetermined, causing difficulties in diagnosis and rela
Autor:
Jessica Ielapi, Salvatore De Rosa, Giuseppe Deietti, Claudia Critelli, Giuseppe Panuccio, Michele Antonio Cacia, Emilia De Luca, Antonio Strangio, Sabato Sorrentino, Alberto Polimeni, Jolanda Sabatino, Antonio Pilò, Carmen Spaccarotella, Annalisa Mongiardo, Ciro Indolfi
Publikováno v:
European Heart Journal Supplements. 23
Aims Acute coronary syndrome (ACS) are a leading cause for mortality and morbility worldwide. Despite ACS usually affects the older population, it also occurs in younger individuals. Young ACS patients (YACS) have a significantly worse prognosis comp
Autor:
Michele Antonio Cacia, Annalisa Mongiardo, Carmen Anna Maria Spaccarotella, Fabiola Boccuto, Serena Serratore, Iolanda Aquila, Giuseppina Mascaro, Ciro Indolfi
Publikováno v:
European Heart Journal Supplements. 23
An 82 years old woman was admitted to our Division for worsening dyspnoea. Her past medical history showed: arterial hypertension, chronic atrial fibrillation on oral anticoagulation, a non-critical single-vessel coronary artery disease, previous mit
Autor:
Antonio Bellantoni, Sabato Sorrentino, Fabiola Boccuto, Nicole Carabett, Salvatore Giordano, Michele Antonio Cacia, Alberto Polimeni, Isabella Leo, Ylenia Varano, Florinda Maria Augusto, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims conduction disturbances requiring pacemaker implantation (PPM) are among the most common complications in patients undergoing transcatheter aortic valve replacement (TAVR). Introduction in clinical practice of a new generation of TAVR devices is
Autor:
Michele Antonio Cacia, Sabato Sorrentino, Isabella Leo, Alberto Polimeni, Jolanda Sabatino, Nadia Salerno, Fabiola Boccuto, Nicole Carabetta, Antonio Bellantoni, Giuseppe Panuccio, Florinda Maria Augusto, Ylenia Varano, Salvatore De Rosa, Annalisa Mongiardo, Carmen AnnaMaria Spaccarotella, Ciro Indolfi
Publikováno v:
European Heart Journal Supplements. 23
Aims A small effective orifice area (EOA) by body surface area (BSA), defined as prosthesis–patient mismatch (PPM), is associated with elevated transprosthetic pressure gradients, less ventricular remodelling, and a worse prognosis. Calculating PPM
Autor:
Fabiola Boccuto, Sabato Sorrentino, Nicole Carabetta, Antonio Bellantoni, Salvatore Giordano, Michele Antonio Cacia, Alberto Polimeni, Isabella Leo, Ylenia Varano, Florinda Maria Augusto, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi, Carmen Spaccarotella
Publikováno v:
European Heart Journal Supplements. 23
Aims Many efforts have been made in the last decade to minimize the risk of bleeding in patients undergoing transcatheter aortic valve replacement (TAVR), such as a less intensive antithrombotic therapy and technical improvement in devices implantati